Cellular mechanisms regulating losartan transfer across brain capillary endothelial cells in primary culture

S.T.P. Pharma Sciences

Volumn 7, Issue 1, 1997, Pages 71-77

  Rose, J M ^a   Audus, K L ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Blood brain barrier; Brain microvessel endothelial cells; Losartan; P glycoprotein

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; LOSARTAN; RHODAMINE 123; VINBLASTINE;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BINDING SITE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CATTLE; CELL CULTURE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BINDING; DRUG PENETRATION; ENDOTHELIUM CELL; INTERNALIZATION; NONHUMAN; TRANSCYTOSIS;

EID: 0031543942     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. JOO F. - The blood-brain barrier in vitro : the second decade. -Neurochem. Int., 23, 499-521, 1993.
2. JOO F. - The blood-brain barrier in vitro : ten years of research on microvessels isolated from the brain. - Neurochem. Int., 7, 1-25, 1985.
3. JOO F. - The cerebral microvessels in culture, an update. - J. Neurochem., 58, 1-17, 1992.
4. AUDUS K.L. and BORCHARDT R.T. - Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. - Pharm. Res., 3, 81-87, 1986.
5. AUDUS K.L. and BORCHARDT R.T. - Characteristics of the large neutral amino acid transport system of bovine brain microvessel endothelial cell monolayers. - J. Neurochem., 47, 484-488, 1986.
6. AUDUS K.L. and BORCHARDT R.T. - Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier. - Ann. NY Acad. Sci., 507, 9-18, 1987.
7. BARANCZYK-KUZMA A., AUDUS K.L. and BORCHARDT R.T. - Catecholamine-metabolizing enzymes of bovine brain microvessel endothelial cell monolayers. - J. Neurochem., 46, 1956-1960, 1986.
8. GUILLOT F.L. and AUDUS K.L. - Angiotensin peptide regulation of fluid-phase endocytosis in brain microvessel endothelial cell monolayers. - J. Cerebr. Blood Flow Metab., 10, 827-834, 1990.
9. PHILLIPS M.I. - Functions of angiotensin in the central nervous system. - Ann. Rev. Physiol., 49, 413-435, 1987.
10. BUI J.D., KIMURA B. and PHILLIPS M.I. - Losartan potassium, a non-peptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier. -Eur. J. Pharmacol., 219, 147-151, 1992.
11. LI Z., BAINS J.S. and FERGUSON A.V. - Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat. - Brain Res. Bull., 30, 33-39, 1993.
12. MARSHALL F.H., CLARK S.A., MICHEL A.D. and BARNES J.C. - Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivo. - Br. J. Pharmacol., 109, 760-764, 1993.
13. SONG K., ZHUO J. and MENDELSOHN F.A.O. - Access of peripherally administered DuP 753 to rat brain angiotensin II receptors. - Br. J. Pharmacol., 104, 771-772, 1991.
14. 1 receptor antagonists to cross the blood-brain barrier in rats. - Eur. J. Pharmacol., 307, 259-267, 1996.
15. GRUBB R.L. and RAICHLE M.E. - Intraventricular angiotensin II increases brain vascular permeability. - Brain Res., 210, 426-430, 1981.
16. OZTAS B. and SANDALCI U. - Reversibility of blood-brain barrier dysfunction in acute hypertension induced by angiotensin. - Exp. Neurol., 84, 666-670, 1984.
17. GUILLOT F.L. and AUDUS K.L. - Some characteristics of specific angiotensin II binding sites on bovine brain microvessel endothelial cell monolayers. - Peptides, 12, 535-540, 1991.
18. MINEO C., YAGYU Y., IMANAKA T. and TAKANO T. -Transcellular transport of angiotensin II through a cultured arterial endothelial monolayer. - Exp. Cell Res., 190, 99-103, 1990.
19. BOWMAN P.D., ENNIS S.R., RAREY K.E., BETZ A.L. and GOLDSTEIN G.W. - Brain microvessel endothelial cells in tissue culture : a model for study of blood-brain barrier permeability. - Ann. Neurol., 14, 396-402, 1983.
20. EGUDINA S.V., STROMSKAYA T.P., FROLOVA E.A. and STAVROVSKAYA A.A. - Early steps of the P-glycoprotein expression in cell cultures studied with vital fluorochrome. -FEBS Lett., 329, 63-66, 1993.
21. HEGMANN E.J., BAUER H.C. and KERBEL R.S. - Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. - Cancer Res., 52, 6969-6975, 1992.
22. LAUTIER D., CANITROT Y. and SALMON J.M. - Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells. -Anticancer Research, 14, 2589-2596, 1994.
23. WANG Q., YANG H., MILLER D.W. and ELMQUIST W.F. -Effect of the P-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain : an in vivo microdialysis study in freely moving rats. - Biochem. Biophys. Res. Commun., 211, 719-726, 1995.
24. JETTE L., MURPHY G.F., LECLERC J. and BELIVEAU R. -Interaction of drugs with P-glycoprotein in brain capillaries. -Biochem. Pharmacol., 50, 1701-1709, 1995.
25. JOLY B., FARDEL O., CECCHELLI R., CHESNE C., PUOZZO C. and GUILLOUZO A. - Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model. -Toxic. in vitro, 9, 357-364, 1995.
26. BARNES J.M., STEWARD L.J., BARBER P.C. and BARNES N.M. - Identification and characterization of angiotensin II receptor subtypes in human brain. - Eur. J. Pharmacol., 230, 251-258, 1993.
27. GEHLERT D.R., GACKENHEIMER S.L. and SCHOBER D.A. -Angiotensin II receptor subtypes in rat brain : dithiothreitol inhibits ligand binding to All-1 and enhances binding to All-2. -Brain Res. 546, 161-165, 1991.
28. SPETH R.C. and HARIK S.I. - Angiotensin II receptor binding sites in brain microvessels. - Proc. Natl. Acad. Sci. USA, 82, 6340-6343, 1985.
29. GUILLOT F.L. and AUDUS K.L. - Angiotensin peptide regulation of bovine brain microvessel endothelial cell monolayer permeability. - J. Cardiovasc. Pharmacol., 18, 212-218, 1991.
30. BIEGEL D., SPENCER D.D. and PACHTER J.S. - Isolation and culture of human brain microvessel endothelial cells for the study of blood-brain barrier properties in vitro. - Brain Res., 692, 183-189, 1995.
31. TATSUTA T., NAITO M., OHARA T., SUGAWARA I. and TSURUO T. - Functional involvement of P-glycoprotein in blood-brain barrier. - J. Biol. Chem., 267, 20383-20391, 1992.
32. TATSUTA T., NAITO M., MIKAMI K. and TSURUO T. - Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells. - Cell Growth and Differ., 5, 1145-1152, 1994.
33. TSUJI A., TAMAI I., SAKATA A., TENDA Y. and TERASAKI T. -Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. - Biochem. Pharmacol., 46, 1096-1099, 1993.
34. BURTON P.S., CONRADI R.A. and HO N.F.H. - Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. - Biochem. Biophys. Res. Commun., 190, 760-766, 1993.
35. NERURKAR M.M., BURTON P.S. and BORCHARDT R.T. -The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. - Pharm. Res., 13, 528-534, 1996.